Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Drug Advertising Oversight Gets A Promotion From A Division To An Office

This article was originally published in The Pink Sheet Daily

Executive Summary

The Division of Drug, Advertising, Marketing and Communications will consist of an office with two divisions, one to review materials for healthcare professionals and other to review direct-to-consumer promotions.
Advertisement

Related Content

FDA’s Promotional Assessments Reorganized Around Specialty, Not Target Audience
FDA’s Rx Enforcement Letter Output Drops In 2011; OPDP Sees Improvement In Promotions
DTC Pre-Review Guidance In The Works For Rx TV Ads, FDA’s Abrams Says
FDA's Office of Medical Policy Grows Into A "Super Office"; DDMAC Gets A Promotion
FDA's Office of Medical Policy Grows Into A "Super Office"; DDMAC Gets A Promotion
DDMAC, Soon To Be An Office, Hones In On DTC Advertising
DDMAC, Soon To Be An Office, Hones In On DTC Advertising
FDA Ad Enforcement Steams On; Are “Days Of Pushing The Envelope” Over?
FDA Ad Enforcement Steams On; Are “Days Of Pushing The Envelope” Over?

Topics

Advertisement
UsernamePublicRestriction

Register

PS070274

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel